Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.280
-0.030 (-2.29%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cardiol Therapeutics Employees
Cardiol Therapeutics had 6 employees as of December 31, 2018.
Employees
6
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$4,458,098
Market Cap
106.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2018 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MultiPlan | 2,800 |
| TriSalus Life Sciences | 112 |
| Tonix Pharmaceuticals Holding | 103 |
| Leap Therapeutics | 54 |
| Acumen Pharmaceuticals | 52 |
| Eupraxia Pharmaceuticals | 29 |
| Protara Therapeutics | 27 |
| MediciNova | 13 |
CRDL News
- 2 days ago - PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis - GlobeNewsWire
- 4 weeks ago - Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024 - Newsfile Corp
- 5 weeks ago - Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index - GlobeNewsWire
- 2 months ago - Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares - Newsfile Corp
- 2 months ago - Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares - Newsfile Corp